Ticagrelor: all 294 studies that test it

Page 1 of 3. Open to participants first (27), then studies with results posted, then the rest; newest registration first within each.

• TicAgreLor Versus Placebo to Prevent Cerebral ISCHemia in anEuRysmal Low Grade SAH A Double Blinded Randomised Controlled StudyNot yet recruitingNCT07821008Phase 3
• Personalizing Thromboprophylaxis for Patients With Peripheral Artery DiseaseRecruitingNCT07613840Not applicable
• Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty.RecruitingNCT07582835Phase 3
• Dual Antiplatelet Therapy Strategies After Acute Myocardial Infarction Undergoing PCI: Prasugrel vs Ticagrelor & 12 Months vs 1-3 MonthsRecruitingNCT07507500Phase 4
• Catequentinib Hydrochloride (AL3818) Drug-Drug Interaction Study in Healthy VolunteersNot yet recruitingNCT07438886Phase 1
• Short-Term Dual Antiplatelet Therapy With Early Transi-tion to Low-dose Antiplatelet Monotherapy Using Ti-cagRelor in Chronic Coronary Artery DiseaseNot yet recruitingNCT07080684Phase 4
• Combining Aspirin With Ticagrelor or Cilostazol in Minor Stroke or TIARecruitingNCT06591390Phase 3
• Combining Aspirin With Ticagrelor or Cilostazol in Large-vessel Minor Stroke or TIARecruitingNCT06591377Phase 3
• Combining Aspirin With Ticagrelor or Clopidogrel in Large-vessel Minor Stroke or TIARecruitingNCT06591338Phase 3
• Combining Aspirin With Ticagrelor or Clopidogrel in Minor Stroke or TIARecruitingNCT06591312Phase 3
• Ticagrelor Versus Cilostazol in Ischemic StrokeRecruitingNCT06561867Phase 3
• Ticagrelore Alone Post PCIRecruitingNCT06509893Phase 4
• A Prospective, Experimental, Multicenter, Open-label, Randomized, Controlled Trial of 3-month Dual Antiplatelet Therapy Followed by Ticagrelor Versus 6-month Dual Antiplatelet Therapy Followed by Ticagrelor After Implanting BridgeRecruitingNCT06301776Not applicable
• Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective Percutaneous Coronary InterventionRecruitingNCT06228456Phase 4
• Ticagrelor Versus Cilostazol in Large-vessel Ischemic StrokeRecruitingNCT06202755Phase 3
• Ticagrelor Versus Cilostazol in Minor Ischemic Stroke or TIARecruitingNCT06196047Phase 3
• Ticagrelor Single Antiplatelet Therapy in Patients With High Risk of Bleeding After DCB for Coronary Small Vessel DiseaseNot yet recruitingNCT06088433Phase 4
• One-Month DAPT in CABG PatientsRecruitingNCT05997693Phase 3
• Pharmacodynamic Outcomes in CCS Patients Treated With an Individualized Treatment StrategyRecruitingNCT05773989Phase 4
• Evaluation of Low Dose Colchicine and Ticagrelor in Prevention of Ischemic Stroke in Patients With Stroke Due to AtherosclerosisRecruitingNCT05476991Phase 3
• Single Antiplatelet Treatment With Ticagrelor or Aspirin After Transcatheter Aortic Valve ImplantationRecruitingNCT05283356Phase 4
• Differential EFfects of Dual antIplatelet and Dual aNtithrombotic thErapy on Hemostasis in Chronic Coronary Syndrome PatientsRecruitingNCT05116995Phase 4
• Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCIRecruitingNCT04695106Phase 4
• A Study of Low Dose vs Standard Ticagrelor on Platelet Function After Intervention for Acute Coronary Syndrome in Senior PatientsRecruitingNCT04307485Phase 4
• A Study of Low and Standard-dose Ticagrelor After Intervention for ACS PatientsRecruitingNCT04255602Phase 4
• Ticagrelor With Low-dose Versus Regular Aspirin in Patients With Acute Coronary Syndrome (ACS) at High-Risk for Ischemia After Percutaneous Coronary InterventionRecruitingNCT04240834Phase 4
• SAPT Versus DAPT in Incomplete Revascularization After CABGRecruitingNCT03789916Phase 3
• A Study to Evaluate BMS-986141 Added on to Aspirin or Ticagrelor or the Combination, on Thrombus Formation in a Thrombosis Chamber Model in Participants With Stable Coronary Artery Disease and Healthy ParticipantsCompletedNCT05093790Phase 2Results posted
• Ticagrelor With and Without Aspirin in Patients With Diabetes MellitusCompletedNCT04484259Phase 4Results posted
• Tailoring P2Y12 Inhibiting Therapy in Patients Requiring Oral Anticoagulation After PCICompletedNCT04483583Phase 4Results posted
• The Value of Screening for HPR in Patients Undergoing Lower Extremity Arterial Endovascular InterventionsTerminatedNCT04007055Phase 3Results posted
• Chewed Versus Integral Pill of TicagrelorCompletedNCT03708588Phase 4Results posted
• Chronic Kidney Disease (CKD) Platelet StudyCompletedNCT03649711Phase 3Results posted
• Effect of Ticagrelor vs. Placebo in the Reduction of Vaso-occlusive Crises in Pediatric Patients With Sickle Cell DiseaseTerminatedNCT03615924Phase 3Results posted
• Prasugrel Versus Ticagrelor in Patients With CYP2C19 Loss-of-function: a Validation StudyCompletedNCT03489863Phase 4Results posted
• Fentanyl and Crushed Ticagrelor in Percutaneous Coronary InterventionTerminatedNCT03476369Phase 4Results posted
• Low Maintenance Dose Ticagrelor Versus Clopidogrel in Diabetes Patients Undergoing PCICompletedNCT03437044Phase 4Results posted
• Efficacy and Safety of Low-dose TicagrelorCompletedNCT03381742Phase 2/3Results posted
• THALES - Acute STroke or Transient IscHaemic Attack Treated With TicAgreLor and ASA for PrEvention of Stroke and DeathCompletedNCT03354429Phase 3Results posted
• CES1 Crossover Trial of Clopidogrel and TicagrelorCompletedNCT03161678Phase 4Results posted
• Antiplatelet Therapy Effect on Extracellular Vesicles in Acute Myocardial InfarctionCompletedNCT02931045Phase 4Results posted
• Crushed Ticagrelor Versus Eptifibatide Bolus + ClopidogrelCompletedNCT02925923Phase 2Results posted
• Ticagrelor in Methotrexate-Resistant Rheumatoid ArthritisCompletedNCT02874092Phase 4Results posted
• Clopidogrel Versus Ticagrelor in Type-2 DiabetesCompletedNCT02742987Phase 4Results posted
• The Effect of IV Cangrelor and Oral Ticagrelor StudyCompletedNCT02733341Phase 4Results posted
• Impact of Chronic Kidney Disease on the Effects of Ticagrelor in Patients With Diabetes and Coronary Artery DiseaseCompletedNCT02539160Phase 4Results posted
• Ticagrelor Therapy for RefrACTORy Migraine StudyCompletedNCT02518464Phase 4Results posted
• Inflammation and Thrombosis in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement (TAVR)CompletedNCT02486367Phase 4Results posted
• A Study to Assess the Effect of Ticagrelor in Reducing the Number of Days With Pain in Patients With Sickle Cell DiseaseCompletedNCT02482298Phase 2Results posted
• Brilinta Taiwan Post Approval Safety StudyCompletedNCT02406248Phase 4Results posted
• P3AMI Antiplatelet TrialCompletedNCT02376283Phase 4Results posted
• Determine the Safety/Efficacy of Ticagrelor for Maintaining Patency of Arterio-Venous Fistulae Created for HemodialysisCompletedNCT02335099Phase 1/2Results posted
• Comparative Efficacy of Ticagrelor Versus Aspirin on Blood Viscosity in Peripheral Artery Disease Patients With Type 2 DiabetesCompletedNCT02325466Phase 3Results posted
• A Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Participants With Acute Coronary SyndromeCompletedNCT02293395Phase 2Results posted
• Study of Ticagrelor Versus Aspirin Treatment in Patients With Myocardial Injury Post Major Non-cardiac SurgeryTerminatedNCT02291419Phase 4Results posted
• NIRS Ticagrelor EvaluationCompletedNCT02282332Phase 4Results posted
• Establishing the Microcirculatory Effects of Ticagrelor on Tissue Perfusion in Critical Limb IschemiaTerminatedNCT02230527Phase 2/3Results posted
• Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVRTerminatedNCT02227368Phase 2Results posted
• Antiplatelet Therapy After Cardiac ArrestCompletedNCT02224274Phase 4Results posted
• Different Antiplatelet Therapy Strategy After Coronary Artery Bypass Graft SurgeryCompletedNCT02201771Phase 4Results posted
• Reversing Ticagrelor's Effects With Fresh PlateletsCompletedNCT02201394Phase 4Results posted
• Switch to Ticagrelor in Critical Limb Ischemia Anti-platelet StudyCompletedNCT02091921Phase 1/2Results posted
• In Vitro Pharmacodynamic Effects of Cangrelor in Ticagrelor Treated PatientsCompletedNCT02081443Not applicableResults posted
• Prasugrel and Ticagrelor in ST-segment Elevation Myocardial InfarctionTerminatedNCT02075125Phase 3Results posted
• A Pharmacodynamic Study Comparing Prasugrel Versus Ticagrelor in Patients Undergoing PCI With CYP2C19 Loss-of-function:CompletedNCT02065479Phase 4Results posted
• Ticagrelor China Pharmacokinetic/Pharmacodynamic StudyCompletedNCT02064985Phase 4Results posted
• Ticagrelor Antiplatelet Therapy to Reduce Graft Events and ThrombosisCompletedNCT02053909Phase 4Results posted
• Ticagrelor vs Clopidogrel in Non-ST Elevation Acute Coronary Syndrome Patients Undergoing PCI With Bivalirudin.TerminatedNCT02052635Phase 4Results posted
• Pharmacokinetics, Pharmacodynamics, and Safety Study of Ticagrelor in Hemodialysis Patients and Healthy SubjectsCompletedNCT02022748Phase 1Results posted
• Pharmacodynamic Evaluation of Switching From Prasugrel to TicagrelorCompletedNCT02016170Not applicableResults posted
• Ticagrelor in Severe Community Acquired PneumoniaTerminatedNCT01998399Phase 2Results posted
• [SOCRATES -Acute Stroke Or Transient IsChaemic Attack TReated With Aspirin or Ticagrelor and Patient OutcomES]CompletedNCT01994720Phase 3Results posted
• A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes MellitusCompletedNCT01991795Phase 3Results posted
• Different LD of Ticagrelor for Antiplatelet Effect in Patients With Non-ST-segment Elevation ACS Undergoing PCICompletedNCT01962428Phase 4Results posted
• Ticagrelor and Eptifibatide Bolus-Only Versus Ticagrelor and Eptifibatide Bolus Plus Abbreviated InfusionCompletedNCT01919723Phase 2Results posted
• High Ticagrelor Loading Dose in STEMICompletedNCT01898442Phase 2Results posted
• Brilinta DaYu StudyCompletedNCT01870921Phase 4Results posted
• A Phase IV Study of the Onset and Maintenance of the Antiplatelet Effect of Ticagrelor Compared With Clopidogrel in Chinese Patients With ACSCompletedNCT01864005Phase 4Results posted
• Pharmacodynamic Effect of Prasugrel vs. Ticagrelor in DiabetesCompletedNCT01852214Not applicableResults posted
• Pharmacodynamic Effects of Prasugrel Compared With Ticagrelor in Patients With Coronary Artery DiseaseCompletedNCT01852175Not applicableResults posted
• Ticagrelor Versus Clopidogrel in Type 2 Diabetic PatientsCompletedNCT01823510Phase 4Results posted
• Cangrelor Ticagrelor Transition StudyCompletedNCT01766466Phase 2Results posted
• Investigation of Drug-drug Interaction of Dabigatran and TicagrelorCompletedNCT01734772Phase 1Results posted
• A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery DiseaseCompletedNCT01732822Phase 3Results posted
• Impact of Ticagrelor Re-load on Pharmacodynamic ProfilesCompletedNCT01731041Not applicableResults posted
• Antithrombotic Effects of Ticagrelor Versus ClopidogrelCompletedNCT01642238Phase 4Results posted
• Ad Hoc Percutaneous Coronary Intervention Study in Acute Coronary Syndrome PatientsCompletedNCT01603082Phase 4Results posted
• Investigation of Pharmacodynamic Effects of Dabigatran and Ticagrelor and Assessment of Ticagrelor Interaction Potential With DabigatranCompletedNCT01595854Phase 1Results posted
• A Pharmacodynamic Study With Ticagrelor in African American PatientsCompletedNCT01523392Phase 4Results posted
• A Pharmacodynamic Study With Ticagrelor in Hispanic PatientsCompletedNCT01523366Phase 4Results posted
• A 30 Day Study to Evaluate Efficacy and Safety of Pre-hospital vs. In-hospital Initiation of Ticagrelor Therapy in STEMI Patients Planned for Percutaneous Coronary Intervention (PCI)CompletedNCT01347580Phase 4Results posted
• Study to Assess Safety and Efficacy of Ticagrelor (AZD6140) Versus Clopidogrel in Asian/Japanese Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS)CompletedNCT01294462Phase 3Results posted
• Prevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of AspirinCompletedNCT01225562Phase 3Results posted
• An Asian Study to Assess the Properties and Profile of Ticagrelor in Patients With Stable Coronary Artery DiseaseCompletedNCT01118325Phase 2Results posted
• A Study of the Antiplatelet Effects Comparing Ticagrelor (Ticag. - AZD6140) With Clopidogrel (Clop.) Responder and Non-respondersCompletedNCT00642811Phase 2Results posted
• A Study of the Onset and Offset of Antiplatelet Effects Comparing Ticagrelor, Clopidogrel, and Placebo With AspirinCompletedNCT00528411Phase 2Results posted
• A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary SyndromeCompletedNCT00391872Phase 3Results posted
• Thromboelastography With Platelet Mapping to Guide Antiplatelet Therapy After Lower Extremity RevascularizationActive, not recruitingNCT07597239Not applicable
• A Drug-drug Interaction Study of YZJ-1139 Tablets and Ticagrelor Tablets in Healthy SubjectsCompletedNCT06671470Phase 1
• TISSARA Trial: Ticagrelor Intervention to Reduce Stent Thrombosis and Acute MI RiskCompletedNCT06667349Phase 4

← Ticagrelor overview